Skip to main content
Skip to footer
About
Overview
Leadership
Board of directors
Contact
Science
Overview
IL-1β in HS
IL-1β in CPPD
Pipeline
Overview
AVTX-009 for HS
AVTX-009 for CPPD
Patients
Our commitment
Clinical trials
Resources
Access to investigational therapies
Investors
Overview
News, events & presentations
Analyst coverage
Stock data
SEC filings
Corporate governance
IR resources
Careers
Overview
Values
Benefits
Job openings
Annual Report & Proxy
2024 Annual Report
2025 Proxy Statement
rss_feed
RSS
Contact IR
RSS
Email Alerts
Accessibility
accessibility
